GI Innovation Inc
358570
Company Profile
Business description
GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.
Contact
Songpa-daero 167
Room 1116 of A-dong
Songpa-gu
Seoul05855
KORT: +82 24042003
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
81
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,381.40 | 7.40 | 0.09% |
CAC 40 | 7,727.93 | 42.55 | -0.55% |
DAX 40 | 23,344.54 | 257.89 | 1.12% |
Dow JONES (US) | 41,218.83 | 98.60 | -0.24% |
FTSE 100 | 8,596.35 | 99.55 | 1.17% |
HKSE | 22,658.98 | 154.30 | 0.69% |
NASDAQ | 17,844.24 | 133.49 | -0.74% |
Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
NZX 50 Index | 12,433.93 | 12.68 | 0.10% |
S&P 500 | 5,650.38 | 36.29 | -0.64% |
S&P/ASX 200 | 8,163.50 | 5.70 | 0.07% |
SSE Composite Index | 3,309.95 | 30.91 | 0.94% |